FDA Clearance Tracker · P980035-S475
ADAPTA, VERSA, SENSIA IPD; RELIA IPG.
Last checked: Nov 20, 2026Latest source record: Mar 24, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Mar 24, 2017
Approved
Time to decision
193 days
Received Sep 12, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P980035-S475
- Device name
- ADAPTA, VERSA, SENSIA IPD; RELIA IPG.
- Applicant
- Medtronic, Inc.
- Applicant location
- Mounds View, MN
- Received
- Sep 12, 2016
- Decided
- Mar 24, 2017
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P980035
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval for hardware, firmware, labeling, and manufacturing changes to the Adapta, Versa, Sensia, and Relia Implantable Pulse Generator families.
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.